Menu

young girl drinking water from water fountain

Chronic Disease Prevention

Advancing evidence-based chronic disease prevention strategies

Our Impact

See all Chronic Disease Prevention Impacts

Children in physical education class
  • 10 years longer life among those with sickle cell disease
  • $15M budget appropriation to help 2 million with asthma
  • 13M low-income Californians meeting federal nutrition guidelines

Our Work

Chronic diseases such as heart disease, cancer, diabetes and asthma are leading causes of death and disability in the U.S. They are also a growing health problem in lowincome countries around the world. These diseases disproportionately affect communities of color and low-income populations, and are responsible for close to 75 percent of all U.S. health care costs.

Successful prevention strategies begin with recognizing the complex interplay of social factors that drive chronic disease, including poverty, racism, education, access to care and local community environments.

At PHI, we oversee a diverse portfolio of cutting-edge chronic disease prevention programs that collectively work to address these social determinants of health, with an emphasis on policy and systems change to have the broadest impact.

PHI Priority

Building Health Equity

Policy change can quickly impact large-scale inequities. In California, PHI co-sponsored a state-wide initiative that doubled the value of SNAP benefits (food stamps) when recipients purchase California-grown fruits and vegetables.

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Close

New PHI Study on Breakthrough Infection Shows Steep Vaccine Efficacy Decline Over Six Months

A PHI study in the journal Science analyzed COVID infection by vaccination status among 780,225 Veterans. Researchers found that protection against any COVID-19 infection declined for all vaccine types, with overall vaccine protection declining from 87.9% in February to 48.1% by October 2021.

See the press release

Continue to PHI.org